Extension of Reexportation Period.
Key claim: Companies would have one year instead of six months after U.S. customs release to reexport controlled substances from the United States to countries outside Europe.
Abstract
(Proposed Rule · Justice Department, Drug Enforcement Administration) This proposed rule would amend the regulations of the Drug Enforcement Administration (DEA) to extend the time allowed for reexports of controlled substances outside of the European Economic Area from 180 days from the date of original release from U.S. Customs and Border Protection to 365 days from that original release date.
Why this matters
Reexport timelines are a key compliance constraint for pharmaceutical distributors moving DEA-controlled substances through U.S. territory to third-country markets. Doubling the window from six months to one year gives exporters more flexibility to consolidate shipments, manage warehousing, and absorb logistics delays without triggering licensing or disposal obligations. The change is narrow but materially eases administrative burden for a small set of controlled-substance exporters serving non-European destinations.